▼ SELL
$ Value
$24K
Shares
4,509
Price
$5
Filed
Dec 11
Insider
Name
Zindrick Thomas
Title
President and CEO
CIK
0001937573
Roles
Officer
Transaction Details
Transaction Date
2025-11-17
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
538,431
Footnotes
Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units. | The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025, and 1,452 shares acquired under the Issuer's Employee Stock Purchase Plan on November 14, 2025.
Filing Info
Zindrick Thomas's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-24 | GNLX | ▼ | $9K |
| 2025-11-17 | GNLX | ▼ | $24K |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
| 2025-09-01 | GNLX | D | — |
| 2025-09-01 | GNLX | A | — |
Other Insiders at GNLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Yu Yong / Cappello Joseph
SVP, Clinical Development
|
— | $2K | 2026-03-24 |
|
Zindrick Thomas
President and CEO
|
— | $9K | 2026-03-24 |
| Thomas John | — | $29K | 2026-03-02 |
|
Smalling Ralph
Head of Regulatory
|
— | $1K | 2026-03-25 |